Trial Outcomes & Findings for Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction (NCT NCT03923790)

NCT ID: NCT03923790

Last Updated: 2022-11-09

Results Overview

Blood pressure will be assessed with an ambulatory blood pressure monitor (ABPM).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

83 participants

Primary outcome timeframe

6 months after enrollment

Results posted on

2022-11-09

Participant Flow

Participant milestones

Participant milestones
Measure
STOP Model
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Overall Study
STARTED
42
41
Overall Study
COMPLETED
27
17
Overall Study
NOT COMPLETED
15
24

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
STOP Model
n=42 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=41 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Total
n=83 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
35 Participants
n=99 Participants
36 Participants
n=107 Participants
71 Participants
n=206 Participants
Age, Categorical
>=65 years
7 Participants
n=99 Participants
5 Participants
n=107 Participants
12 Participants
n=206 Participants
Age, Continuous
55.5 years
STANDARD_DEVIATION 11.6 • n=99 Participants
53.4 years
STANDARD_DEVIATION 10.1 • n=107 Participants
54.5 years
STANDARD_DEVIATION 10.9 • n=206 Participants
Sex: Female, Male
Female
20 Participants
n=99 Participants
23 Participants
n=107 Participants
43 Participants
n=206 Participants
Sex: Female, Male
Male
22 Participants
n=99 Participants
18 Participants
n=107 Participants
40 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
11 Participants
n=99 Participants
9 Participants
n=107 Participants
20 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
31 Participants
n=99 Participants
31 Participants
n=107 Participants
62 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=99 Participants
3 Participants
n=107 Participants
4 Participants
n=206 Participants
Race (NIH/OMB)
Asian
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
20 Participants
n=99 Participants
17 Participants
n=107 Participants
37 Participants
n=206 Participants
Race (NIH/OMB)
White
13 Participants
n=99 Participants
13 Participants
n=107 Participants
26 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants
n=99 Participants
6 Participants
n=107 Participants
13 Participants
n=206 Participants
Region of Enrollment
United States
42 Participants
n=99 Participants
41 Participants
n=107 Participants
83 Participants
n=206 Participants
Number of participants who are insured
13 Participants
n=99 Participants
13 Participants
n=107 Participants
26 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 6 months after enrollment

Population: Data for this outcome measure were not collected for 16 in the STOP Model arm and 25 in the Usual Care arm.

Blood pressure will be assessed with an ambulatory blood pressure monitor (ABPM).

Outcome measures

Outcome measures
Measure
STOP Model
n=26 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=16 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Daytime Ambulatory Systolic Blood Pressure
123.6 millimeters of mercury (mmHg)
Standard Deviation 16.7
128.3 millimeters of mercury (mmHg)
Standard Deviation 19.7

SECONDARY outcome

Timeframe: 6 months

Population: Data for this outcome measure were not collected for 16 in the STOP Model arm and 25 in the Usual Care arm.

Blood pressure will be assessed with an ambulatory blood pressure monitor (ABPM).

Outcome measures

Outcome measures
Measure
STOP Model
n=26 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=16 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Daytime Ambulatory Diastolic Blood Pressure
75.1 millimeters of mercury (mmHg)
Standard Deviation 9.6
76.5 millimeters of mercury (mmHg)
Standard Deviation 13.7

SECONDARY outcome

Timeframe: 6 months

Population: Data for this outcome measure were not collected for 16 in the STOP Model arm and 29 in the Usual Care arm.

Blood pressure will be assessed with an ambulatory blood pressure monitor (ABPM).

Outcome measures

Outcome measures
Measure
STOP Model
n=26 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=12 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Night Time Ambulatory Systolic Blood Pressure
117.3 millimeters of mercury (mmHg)
Standard Deviation 16
119.3 millimeters of mercury (mmHg)
Standard Deviation 19.3

SECONDARY outcome

Timeframe: 6 months

Population: Data for this outcome measure were not collected for 16 in the STOP Model arm and 29 in the Usual Care arm.

Blood pressure will be assessed with an ambulatory blood pressure monitor (ABPM).

Outcome measures

Outcome measures
Measure
STOP Model
n=26 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=12 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Nighttime Diastolic Blood Pressure
69.4 millimeters of mercury (mmHg)
Standard Deviation 8.9
68 millimeters of mercury (mmHg)
Standard Deviation 13.7

SECONDARY outcome

Timeframe: 6 months

Population: Data for this outcome measure were not collected for 22 in the STOP Model arm and 29 in the Usual Care arm.

BMI will be calculated from height and weight.

Outcome measures

Outcome measures
Measure
STOP Model
n=20 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=12 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Body Mass Index(BMI)
33.8 kilograms/meter^2 (kg/m^2)
Standard Deviation 7.4
27.7 kilograms/meter^2 (kg/m^2)
Standard Deviation 3.9

SECONDARY outcome

Timeframe: 6 months

Recurrent vascular events include stroke, myocardial infarction, or acute cardiac death.

Outcome measures

Outcome measures
Measure
STOP Model
n=42 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=41 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Number of Participants With Recurrent Vascular Events (Stroke, Myocardial Infarction, Acute Cardiac Death)
3 Participants
2 Participants

SECONDARY outcome

Timeframe: 6 months

Acute healthcare utilization includes hospital readmission and acute care visits to emergency room and/or urgent care.

Outcome measures

Outcome measures
Measure
STOP Model
n=42 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=41 Participants
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
Number of Participants With Acute Healthcare Utilization
2 Participants
2 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline

Outcome measures

Outcome data not reported

Adverse Events

STOP Model

Serious events: 4 serious events
Other events: 1 other events
Deaths: 1 deaths

Usual Care

Serious events: 2 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
STOP Model
n=27 participants at risk
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=17 participants at risk
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
General disorders
Hospitalization
7.4%
2/27 • Number of events 2 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.
11.8%
2/17 • Number of events 2 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.
General disorders
Hospitalization due to injury from fall
3.7%
1/27 • Number of events 1 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.
0.00%
0/17 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.
General disorders
Death
3.7%
1/27 • Number of events 1 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.
0.00%
0/17 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.

Other adverse events

Other adverse events
Measure
STOP Model
n=27 participants at risk
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet and a blue tooth enabled BP monitor with an iPad and will also receive educational messages every other week by phone. A video telehealth visit occurs 7 days after discharge attended by a nurse practitioner (NP) or MD , social worker (SW), and pharmacist. The NP and pharmacist review the BP data to determine the need for medication adjustment. The SW assesses the need for resources. BP is reviewed via an online portal every 2 weeks until average BP is \< 130/80mmHg, then monthly. Uncontrolled BP prompts a call from the pharmacist to discuss medication adherence and titration. Subsequent video telehealth visits occur 1 month, 3 months, and 5 months after enrollment.
Usual Care
n=17 participants at risk
Pharmacist evaluates patient prior to discharge and a nurse navigator contacts patient 72 hours after discharge. Patient receives educational packet. Educational Packet: The patient will receive an educational packet. Phone call at 72 hours by discharge nurse navigator: Patients will receive a phone call at 72 hours by the discharge nurse navigator (standard of care) to assure that they have received their medications and follow-up appointments
General disorders
Fall
3.7%
1/27 • Number of events 1 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.
11.8%
2/17 • Number of events 2 • 6 months
Mortality data were collected for all participants who were randomized. Serious Adverse Event data and Other (Not Including Serious) Adverse Event data were collected for participants who completed the study.

Additional Information

Anjail Sharrief, MD, MPH, Associate Professor

The University of Texas Health Science Center at Houston

Phone: 713-500-6538

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place